Safety And Prognosis Of The Operation Of Borehole Drainage For Hematoma In Patients With Long-term Oral Aspirin Intracerebral Hemorrhage

Objective: Investigate the safety of Borehole drainage in patients with aspirin intracerebral hemorrhage by observing the long-term oral aspirin and non-aspirin patients with ich.Methods: A retrospective statistical analysis,the south China university of changsha affiliated hospital neurosurgery from January 2014 to December 2018 during 115 treated by routine supratentorial cerebral hemorrhage patients with Borehole drainage,according to the corresponding into and exclusion criteria,the long-term aspirin patients in group A,patients who were not taking aspirin in group B.The basic information of the two groups of patients was analyzed,including preoperative Glasgow score(GCS score),age,gender,preoperative cerebral hemorrhage amount,bleeding site and other factors,intraoperative blood loss,rate of rebleeding after Borehole drainage,mortality,and GOS score 6 months after surgery.The effects of aspirin on the safety,intraoperative bleeding and long-term prognosis of supratentorial intracerebral hemorrhage were analyzed.Results:There were no statistically significant differences between the two groups in gender,age,preoperative GCS,preoperative hematoma size,operative time,intraoperative hemorrhage,postoperative hematoma cavity drainage tube retention time,intracranial infection rate,and GCS score 1 month after Borehole drainage(P>0.05).The rate of rebleeding in group A(21.4%)and group B(8.2%)was statistically significant(P=0.043).The mortality rates of group A(26.2%)and group B(10.9%)were statistically significant(P=0.034).6 months after Borehole drainage,the long-term prognosis was good in group A(14.2%)and group B(27.4%),and the difference was statistically significant(P=0.02).Conclusion:1.The rate of postoperative rebleeding and mortality of patients with cerebral hemorrhage in the aspirin group was significantly higher than that in the non-aspirin group.2.There was no difference between the short-term prognosis of patients with cerebral hemorrhage who received aspirin and those who did not take aspirin and the long-term prognosis was worse than those who did not take aspirin.3.There was no increase in intraoperative blood loss in patients with intracerebral hemorrhage who took aspirin.the operation was safe and feasible.Preoperative measures to reverse the function of aspirin and reduce the rate of rebleeding were likely to achieve a better prognosis.